Your browser doesn't support javascript.
loading
[Diagnoses and new therapeutic strategy focused on physiological alteration of tryptophan metabolism].
Mouri, Akihiro; Hasegawa, Masaya; Kunisawa, Kazuo; Saito, Kuniaki; Nabeshima, Toshitaka.
Afiliación
  • Mouri A; Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences.
  • Hasegawa M; Japanese Drug Organization of Appropriate Use and Research.
  • Kunisawa K; Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences.
  • Saito K; Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences.
  • Nabeshima T; Japanese Drug Organization of Appropriate Use and Research.
Nihon Yakurigaku Zasshi ; 158(3): 233-237, 2023 May 01.
Article en Ja | MEDLINE | ID: mdl-36990795
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Triptófano / Trastorno Depresivo Mayor Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: Ja Revista: Nihon Yakurigaku Zasshi Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Triptófano / Trastorno Depresivo Mayor Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: Ja Revista: Nihon Yakurigaku Zasshi Año: 2023 Tipo del documento: Article